Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1991;17:63-71

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeffries, W. B.
Right arrow Articles by Pettinger, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeffries, W. B.
Right arrow Articles by Pettinger, W. A.

Hypertension, Vol 17, 63-71, Copyright © 1991 by American Heart Association


ARTICLES

Vasopressin response in collecting ducts of rats resistant to mineralocorticoid hypertension

WB Jeffries, S McArdle, C Bockman, PW Abel and WA Pettinger
Department of Medicine, Creighton University School of Medicine, Omaha, Neb.

In previous studies we found that vasopressin stimulation of both cyclic AMP (cAMP) formation in cortical collecting tubules (CCT) and sodium reabsorption in isolated perfused kidneys was markedly exaggerated in rats with mineralocorticoid hypertension. In the present study, we tested the response (cAMP accumulation) of cortical and outer medullary collecting tubules (OMCT) to vasopressin in two rat models that are resistant to deoxycorticosterone acetate (DOCA)-induced hypertension, the Wistar-Furth strain and NaCl-deficient rats. The blood pressure of normal outbred Wistar rats rose to hypertensive levels (systolic pressure more than 165 mm Hg) during a 5-week treatment with DOCA (10 mg/week) and 1% saline to drink. Significant hypertrophy of the heart and kidneys was also observed. Vasopressin (10(-8) M)-induced cAMP formation was enhanced 3.4-fold in the CCT (OMCT unchanged) of hypertensive rats compared with normotensive controls. Significant hypertrophy (as indexed by tubule diameter) of the CCT but not the OMCT was also observed in DOCA-salt hypertensive rats. Restriction of dietary NaCl (0.13% in chow, tap water to drink) completely prevented DOCA-induced hypertension, organ and CCT hypertrophy, and enhancement of vasopressin-stimulated cAMP formation in the CCT. In Wistar-Furth rats, DOCA-salt treatment did not alter blood pressure or cause significant organ hypertrophy. However, DOCA- salt treatment enhanced vasopressin-stimulated cAMP formation by 4.1- fold in CCT of Wistar-Furth rats, with significant tubular hypertrophy in the CCT but not the OMCT. We conclude that DOCA-induced hypertension and changes in CCT function are dependent on excess dietary NaCl.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
HypertensionHome page
M. E. Ullian, C. J. Robinson, C. T. B. Evans, J. Z. Melnick, and W. R. Fitzgibbon
Role of Citrate Synthase in Aldosterone-Mediated Sodium Reabsorption
Hypertension, April 1, 2000; 35(4): 875 - 879.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
W. R. FITZGIBBON, E. L. GREENE, J. S. GREWAL, F. N. HUTCHISON, S. E. SELF, S. Y. LATTEN, and M. E. ULLIAN
Resistance to Remnant Nephropathy in the Wistar-Furth Rat
J. Am. Soc. Nephrol., April 1, 1999; 10(4): 814 - 821.
[Abstract] [Full Text]